Cargando…
1114. Oral β-lactams for the Treatment of Escherichia coli Bacteremia Secondary to Complicated Urinary Tract Infections Including Pyelonephritis
BACKGROUND: Complicated urinary tract infections (cUTI) including pyelonephritis may result in bacteremia, increasing the rate of morbidity and mortality. The Infectious Diseases Society of America recommends a fluoroquinolone as empiric therapy or trimethoprim/sulfamethoxazole as definitive therapy...
Autores principales: | Harrington, Nicole, Doran, Megan, May, Stephen, Care, Julianne, Laude, Jillian, Lee, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810967/ http://dx.doi.org/10.1093/ofid/ofz360.978 |
Ejemplares similares
-
994. Effect on Β-lactam Usage Following Implementation of Clinical Pharmacy Services to Improve Β-lactam Allergy History Documentation
por: Harrington, Nicole, et al.
Publicado: (2019) -
Virulence Factors Associated With Escherichia coli Bacteremia and Urinary Tract Infection
por: Kim, Bongyoung, et al.
Publicado: (2022) -
Megalocytic Interstitial Nephritis Following Acute Pyelonephritis with Escherichia coli Bacteremia: A Case Report
por: Kwon, Hee Jin, et al.
Publicado: (2015) -
883. Evaluation of Post-operative Antibiotic Prophylaxis in Patients Undergoing Urologic Procedures
por: Elmarakbi, Mohamed, et al.
Publicado: (2020) -
Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia
por: Bai, Anthony D., et al.
Publicado: (2020)